{
    "clinical_study": {
        "@rank": "158014", 
        "acronym": "SOCR", 
        "arm_group": {
            "arm_group_label": "Medtronic Cardiac Resynchronization Therapy Device", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The Sensor Optimization of Cardiac Resynchronization Therapy (CRT) Response (SOCR) Study is\n      a multicenter, prospective, non-randomized acute feasibility study that is being conducted\n      to determine if subcutaneous heart sounds and/or intracardiac impedance can acutely identify\n      the optimal atrioventricular (AV) pacing intervals and optimal left ventricular (LV)\n      electrodes in patients indicated for cardiac resynchronization therapy."
        }, 
        "brief_title": "Sensor Optimization of Cardiac Resynchronization Therapy Response", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject must be undergoing implant of a new or replacement/upgrade Medtronic CRT-P or\n             CRT-D device for approved indications.\n\n          -  Subject is implanted or will be implanted with an right ventricular (RV) lead that\n             supports bipolar pacing and sensing (e.g. a bipolar pace/sense lead or a true bipolar\n             defibrillation leads)\n\n          -  Subject (or subject's legally authorized representative) must be willing to give\n             informed consent\n\n          -  Subjects must be at least 18 years of age\n\n        Exclusion Criteria:\n\n          -  Subject has congenital heart disease\n\n          -  Subject has a tachyarrhythmia (atrial and/or ventricular) at the time of enrollment\n             and a cardioversion will not be attempted prior to the research procedure\n\n          -  Subject has unstable coronary artery disease\n\n          -  Subject cannot undergo transvenous catheterization\n\n          -  Subject has a mechanical tricuspid or aortic valve prosthesis or history of\n             significant structural tricuspid or aortic valvular disease\n\n          -  Subject requires dual chamber cardiac pacing or single chamber (ventricular) pacing\n             at rest for rate control\n\n          -  Subject has a recent echocardiogram (within prior 6 months) which revealed the\n             presence of an LV thrombus\n\n          -  Subject is pregnant\n\n          -  Subject is enrolled in a concurrent study that may confound the results of this study\n             without documented pre-approval from Medtronic study manager"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01832493", 
            "org_study_id": "SOCR"
        }, 
        "intervention": {
            "arm_group_label": "Medtronic Cardiac Resynchronization Therapy Device", 
            "intervention_name": "Medtronic Cardiac Resynchronization Therapy Device", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "November 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43210"
                }, 
                "name": "The Ohio State University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Sensor Optimization of CRT Response", 
        "overall_contact": {
            "email": "medtronicCRMtrials@medtronic.com", 
            "last_name": "SOCR Clinical Trial Leader"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "Canada: Health Canada"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Percentage of subjects where the optimal setting as determined by intracardiac impedance agrees within one AV interval setting of the optimal setting determined by LV dP/dt max.", 
                "safety_issue": "No", 
                "time_frame": "intraoperative testing only"
            }, 
            {
                "measure": "Percentage of subjects where the optimal setting as determined by heart sounds agrees within one AV interval setting of the optimal setting determined by LV dP/dt max.", 
                "safety_issue": "No", 
                "time_frame": "intraoperative testing only"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01832493"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Medtronic Cardiac Rhythm Disease Management", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Medtronic Cardiac Rhythm Disease Management", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}